Richard A. Voit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Richard A. Voit has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Satish Kumar Nandakumar
Albert Einstein College of Medicine 1 Department of Cell Biology Bronx, New York
21 shared publications - Aditi Hegde
Albert Einstein College of Medicine 1 Department of Cell Biology Bronx, New York
20 shared publications - Aruna Shekhar
Albert Einstein College of Medicine 1 Department of Cell Biology Bronx, New York
20 shared publications - Chie Yanase
Albert Einstein College of Medicine 1 Department of Cell Biology Bronx, New York
20 shared publications - Dominika Kwasniak
Albert Einstein College of Medicine 1 Department of Cell Biology Bronx, New York
20 shared publications - Jessica Jeejan
Albert Einstein College of Medicine 1 Department of Cell Biology Bronx, New York
20 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Table S4 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Log2-transformed normalized RNA/DNA ratios between 5 individual MPRA replicates
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Log2-transformed normalized RNA/DNA ratios between 5 individual MPRA replicates
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Results of fine mapping analysis of mutation stratified GWAS using SuSIE
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Results of fine mapping analysis of mutation stratified GWAS using SuSIE
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Table S8 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Gene ontology analysis of unique upregulated pathways - Tet2-/- MSI2 vs. WT HMD
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S8 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Gene ontology analysis of unique upregulated pathways - Tet2-/- MSI2 vs. WT HMD
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Variants per loci tested in MPRA library
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Variants per loci tested in MPRA library
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Table S5 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Enhancer activity for all constructs captured in MPRA using MPRAnalyze
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Enhancer activity for all constructs captured in MPRA using MPRAnalyze
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Allelic skew measurements of CHIP GWAS associated variants using MPRAnalyze
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Allelic skew measurements of CHIP GWAS associated variants using MPRAnalyze
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Table S9 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Gene ontology analysis of unique downregulated pathways - Tet2-/- MSI2 vs. WT HMD
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S9 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Gene ontology analysis of unique downregulated pathways - Tet2-/- MSI2 vs. WT HMD
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Table S7 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Eighty-seven MPRA hits and test variants and their annotations
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S7 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Eighty-seven MPRA hits and test variants and their annotations
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Transcriptional programs induced by MSI2 overexpression in Tet2 null HSPCs.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Transcriptional programs induced by MSI2 overexpression in Tet2 null HSPCs.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Experimental design, library quality, and reproducibility of the CHIP MPRA.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Germline Noncoding Risk Variants Influence Clonal Hematopoiesis through Altered Hematopoietic Enhancer Activity
Experimental design, library quality, and reproducibility of the CHIP MPRA.